1. Home
  2. KZIA vs MARPS Comparison

KZIA vs MARPS Comparison

Compare KZIA & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • MARPS
  • Stock Information
  • Founded
  • KZIA 1994
  • MARPS 1956
  • Country
  • KZIA Australia
  • MARPS United States
  • Employees
  • KZIA N/A
  • MARPS N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • MARPS Oil & Gas Production
  • Sector
  • KZIA Health Care
  • MARPS Energy
  • Exchange
  • KZIA Nasdaq
  • MARPS Nasdaq
  • Market Cap
  • KZIA 6.0M
  • MARPS 8.7M
  • IPO Year
  • KZIA 1999
  • MARPS N/A
  • Fundamental
  • Price
  • KZIA $0.89
  • MARPS $4.03
  • Analyst Decision
  • KZIA Strong Buy
  • MARPS
  • Analyst Count
  • KZIA 2
  • MARPS 0
  • Target Price
  • KZIA $11.50
  • MARPS N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • MARPS 16.4K
  • Earning Date
  • KZIA 03-26-2025
  • MARPS 01-01-0001
  • Dividend Yield
  • KZIA N/A
  • MARPS 8.81%
  • EPS Growth
  • KZIA N/A
  • MARPS N/A
  • EPS
  • KZIA N/A
  • MARPS 0.30
  • Revenue
  • KZIA $1,655,324.00
  • MARPS $945,496.00
  • Revenue This Year
  • KZIA $806.89
  • MARPS N/A
  • Revenue Next Year
  • KZIA N/A
  • MARPS N/A
  • P/E Ratio
  • KZIA N/A
  • MARPS $13.43
  • Revenue Growth
  • KZIA 248000.00
  • MARPS N/A
  • 52 Week Low
  • KZIA $0.89
  • MARPS $3.76
  • 52 Week High
  • KZIA $15.80
  • MARPS $6.50
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 28.96
  • MARPS 49.04
  • Support Level
  • KZIA $0.90
  • MARPS $3.81
  • Resistance Level
  • KZIA $1.60
  • MARPS $4.09
  • Average True Range (ATR)
  • KZIA 0.24
  • MARPS 0.15
  • MACD
  • KZIA 0.01
  • MARPS -0.01
  • Stochastic Oscillator
  • KZIA 0.00
  • MARPS 56.92

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

Share on Social Networks: